Fisher Scientific Reports Record Sales and Cash Flow
Fisher Scientific International Inc. reported its results for the fourth quarter and full year that ended 2004. Highlights of Fisher's performance in 2004 include record sales of $4,662.7 million, a 30.8 percent increase over 2003, and record operating cash flow of $392.8 million.
"We had an outstanding year, achieving record sales due to strong organic growth in our largest business -- scientific products and services -- and contributions from Apogent, Oxoid and Dharmacon," said Paul M. Montrone, chairman and chief executive officer. "We have made considerable progress on the integration of Apogent and are excited about our growth opportunities for 2005 and beyond."
Most read news
Other news from the department business & finance
![Newsletter](https://img.chemie.de/assets/awportal/images/newsletter.png)
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.